Extremely low amounts of GDNF released from their MS (0.8 pg/day) achieved a therapeutic effect on the retina, protecting RGC in a glaucoma model (damage caused by increasing the IOP in a non-aggressive manner). Here, GDNF is linked to glaucoma.